Evidence map›Paper›PMID 30927119›Full record

ArticleJournal of clinical immunology2019

Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2.

Charlotte A Slade, Catriona McLean, Thomas Scerri, Tran Binh Giang, Steven Megaloudis, Alexander Strathmore, Jessica C Tempany, Katherine Nicholls, Colleen D'Arcy, Melanie Bahlo and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases.Multiple sclerosis journal - experimental, translational and clinical
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Charlotte A SladeDepartment of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, 3052, Australia. slade.c@wehi.edu.au.ORCID 0000-0001-9020-1487
Catriona McLeanDepartment of Anatomical Pathology, The Alfred Hospital, Prahran, VIC, 3181, Australia.
Thomas ScerriDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
Tran Binh GiangDepartment of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, 3052, Australia.
Steven MegaloudisDepartment of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, 3052, Australia.
Alexander StrathmoreDepartment of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, 3052, Australia.
Jessica C TempanyImmunology Division, Walter and Eliza Hall Institute for Medical Research, Parkville, VIC, 3052, Australia.
Katherine NichollsDepartment of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, 3052, Australia.
Colleen D'ArcyDepartment of Anatomical Pathology, The Alfred Hospital, Prahran, VIC, 3181, Australia.
Melanie BahloDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia.
Philip D HodgkinImmunology Division, Walter and Eliza Hall Institute for Medical Research, Parkville, VIC, 3052, Australia.
Jo A DouglassDepartment of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, 3052, Australia.
Vanessa L BryantDepartment of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, 3052, Australia.
The Royal Melbourne Hospital · AUThe University of Melbourne · AUThe Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency is the most prevalent of the primary immunodeficiency diseases, yet its pathogenesis is largely poorly understood. Of the cases that are monogenic, many arise due to pathogenic variants in NFKB1 and NFKB2. Here, we report enteroviral encephalomyelitis as the cause of a fatal neurodegenerative condition in a patient with a novel heterozygous mutation in NFKB2 (c.2543insG, p.P850Sfs36*) that disrupts non-canonical NF-κB signaling. Investigations of primary and secondary lymphoid tissue demonstrated a complete absence of B cells and germinal centers. Despite multiple negative viral PCR testing of cerebrospinal fluid during her disease progression, post-mortem analysis of cerebral tissue revealed a chronic lymphocytic meningoencephalitis, in the presence of Cocksackie A16 virus, as the cause of death. The clinical features, and progression of disease reported here, demonstrate divergent clinical and immunological phenotypes of individuals within a single family. This is the first reported case of fatal enteroviral encephalomyelitis in a patient with NF-κB2 deficiency and mandates a low threshold for early brain biopsy and the administration of increased immunoglobulin replacement in any patient with a defect in this pathway and deterioration of neurological status.

Indexed as

BiopsyCells, CulturedChildCommon Variable ImmunodeficiencyEncephalomyelitisEnterovirusEnterovirus InfectionsFatal OutcomeFemaleHumansNeurodegenerative DiseasesNF-kappa B p52 SubunitPedigreeSequence DeletionNF-kappa B p52 SubunitNFKB2 protein, humanCVIDencephalitisenterovirusImmunodeficiencyNF-kappaB2 deficiencyNFKB2

Identifiers

PMID30927119
OpenAlexW2935422456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.